all report title image

GLOBAL ANALGESICS MARKET SIZE AND SHARE ANALYSIS - GROWTH TRENDS AND FORECASTS (2024-2031)

Global Analgesics Market, By Drug Type (Opioid, Non-opioid, Compound medication), By Route of Administration (Oral, Parenteral, Transdermal, Others), By Application (Musculoskeletal, Surgical and Trauma, Cancer, Neuropathic, Migraine, Obstetrical, Fibromyalgia, Pain due to Burns , Dental/Facial, Pediatric, Others), By Pain Type (Acuteand Chronic ), By Distribution Channel (Hospital pharmacies, Retail pharmacies, Online pharmacies), By Geography (North America, Latin America, Europe, Asia Pacific, Middle East & Africa)

  • Published In : Jul 2024
  • Code : CMI7207
  • Pages :170
  • Formats :
      Excel and PDF
  • Industry : Pharmaceutical

Market Concentration and Competitive Landscape

Global Analgesics Market Concentration By Players

Close-monitor your Competitor's Move, Request sample copy

Rising Healthcare Expenditure on Pain Management

Persistent pain takes a huge economic toll globally in terms of lost work productivity and increased healthcare spending on medications, treatments, and physician visits. Providing effective pain relief is important from a humanitarian perspective to enhance patients' quality of life. It also makes economic sense for nations aiming to optimize healthcare resources and productivity levels within the population. Majority of chronic pain sufferers regularly visit multiple physicians and undergo multiple types of treatments from lifestyle therapies to invasive procedures. However, medication continues to be the mainstay of chronic pain management for most patients worldwide. Growing healthcare expenditure on pain management reflects this increasing dependence on analgesic drugs. Rising incomes have raised affordability and willingness to pay for therapeutic options to treat and manage pain conditions. With mounting economic burden of unresolved chronic pain, governments and private insurers are allocating bigger budgets towards pain relief programs and analgesic prescriptions. This boosts demand for pain-related drugs including both generic and patented brands.

Key Players Insights
  • F. Hoffmann-La Roche Ltd.
  • Mylan N.V.
  • Teva Pharmaceutical Industries Ltd.
  • Sanofi
  • Pfizer Inc.
  • GlaxoSmithKline plc
  • Novartis AG
  • Merck & Co., Inc.
  • AstraZeneca
  • Johnson & Johnson Private Limited
  • Hikma Pharmaceuticals PLC
  • Dr. Reddy’s Laboratories Ltd.
  • Fresenius Kabi AG
  • Aurobindo Pharma
  • Bausch Health Companies Inc.
  • Amneal Pharmaceuticals LLC.
  • Apotex Inc.
  • Eli Lilly and Company
  • Cipla Inc.
  • Lupin

Need a Custom Report?

We can customize every report - free of charge - including purchasing stand-alone sections or country-level reports

Customize Now
Logo

Credibility and Certifications

ESOMAR
DUNS Registered
Clutch
DMCA Protected

9001:2015

Credibility and Certifications

27001:2022

Credibility and Certifications

EXISTING CLIENTELE

Joining thousands of companies around the world committed to making the Excellent Business Solutions.

View All Our Clients
trusted clients logo
© 2024 Coherent Market Insights Pvt Ltd. All Rights Reserved.